高盛：中国医疗-关于关税影响的分析，总体而言对我们所涵盖的内容影响有限，正等待有关潜在制药方面的最新消息

16 April 2025 | 11:24PM HKT China Healthcare Analysis on the tariff impact, overall limited for our coverage, awaiting updates on potential pharmaceutical In this report we provide an updated view of the potential tariff impact on our covered China Healthcare names across various sub-sectors and sensitivity analysis for key names, following our previous report in Feb 2025 (link). We see the tariff impact on our covered Chinese healthcare names as manageable, while we await clarity on potential sector-specif ...